Stock Events

Stock Events

Roche 

$56.66
1995
-$0.09-0.16% Today

Statistics

Day High
57.11
Day Low
56.51
52W High
57.02
52W Low
35.81
Volume
330,122
Avg. Volume
2,574,255
Mkt Cap
0
P/E Ratio
22.08
Dividend Yield
2.45%
Dividend
1.39

Upcoming

30
MAR
Dividend Ex
Estimated
 
15
MAY
Dividend Payment
Estimated
 
29
MAR 27
Dividend Ex
Estimated
 
14
MAY 27
Dividend Payment
Estimated
 
28
MAR 28
Dividend Ex
Estimated
 

Dividends

2.45%Dividend Yield
May 25
$1.39
May 24
$1.35
Mar 23
$1.28
Mar 22
$1.24
Mar 21
$1.22
10Y Growth
3.16%
5Y Growth
2.62%
3Y Growth
2.78%
1Y Growth
N/A

Earnings

29JanExpected
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
0
4.66
9.31
13.97
Expected EPS
10.8278576
Actual EPS
10.570532

Financials

13.7%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
133.64BRevenue
18.31BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RHHBY. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap237.61B
Novartis competes directly with Roche in multiple areas including oncology, neuroscience, and immunology, making it a primary competitor.
Pfizer
PFE
Mkt Cap140.15B
Pfizer competes with Roche in the pharmaceutical sector, particularly in the development of cancer and immunology drugs.
Merck
MRK
Mkt Cap214.76B
Merck is a key competitor in the oncology space, directly competing with Roche's cancer drug portfolio.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson competes across a broad range of healthcare products, including pharmaceuticals that overlap with Roche's offerings.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie competes in the biopharmaceutical field, particularly in areas like immunology and oncology, overlapping with Roche's interests.
AMGEN
AMGN
Mkt Cap160.66B
Amgen competes with Roche in the biotech sector, especially in cancer and hematology.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb competes in the pharmaceutical and biopharmaceutical sectors, particularly in cancer, which is a key area for Roche.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline competes with Roche in several areas including pharmaceuticals and vaccines.
Sanofi
SNY
Mkt Cap124.45B
Sanofi competes with Roche in the pharmaceutical sector, including treatments for rare diseases, which Roche also focuses on.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca competes with Roche in the development of drugs for various diseases, including cancer, respiratory, and cardiovascular diseases.

About

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Show more...
CEO
Dr. Severin Schwan Ph.D.
Employees
103249
Country
CH
ISIN
US7711951043

Listings

MI
IT
1ROG.MI
MI
IT
1RO.MI
F
DE
RHO5.F
XETRA
DE
RHO.XETRA

0 Comments

Share your thoughts

FAQ

What is Roche stock price today?▼
The current price of RHHBY is $56.66 USD — it has decreased by -0.16% in the past 24 hours. Watch Roche stock price performance more closely on the chart.
What is Roche stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Roche stocks are traded under the ticker RHHBY.
Is Roche stock price growing?▼
RHHBY stock has risen by +0.96% compared to the previous week, the month change is a +10.19% rise, over the last year Roche has showed a +44.32% increase.
When is the next Roche earnings date?▼
Roche is going to release the next earnings report on July 23, 2026.
What were Roche earnings last quarter?▼
RHHBY earnings for the last quarter are 10.57 USD per share, whereas the estimation was 10.83 USD resulting in a -2.38% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Roche revenue for the last year?▼
Roche revenue for the last year amounts to 133.64B USD.
What is Roche net income for the last year?▼
RHHBY net income for the last year is 18.31B USD.
Does Roche pay dividends?▼
Yes, RHHBY dividends are paid annual. The last dividend per share was 1.39 USD. As of today, Dividend Yield (FWD)% is 2.45%.
How many employees does Roche have?▼
As of February 02, 2026, the company has 103,249 employees.
In which sector is Roche located?▼
Roche operates in the Health Care sector.
When did Roche complete a stock split?▼
The last stock split for Roche was on February 27, 2014 with a ratio of 2:1.
Where is Roche headquartered?▼
Roche is headquartered in Basel, CH.